BRIGHT MINDS BIOSCIENCES INC.（DRUG）適時開示・決算発表
| 提出日 | 様式 | 項目 | 原文 |
|---|---|---|---|
| 2026-08-17 | 6-K | FORM 6-K | SEC |
| 2026-06-03 | 6-K | FORM 6-K | SEC |
| 2026-06-02 | 6-K | FORM 6-K | SEC |
| 2026-05-28 | 6-K | — | SEC |
| 2026-05-20 | 6-K | FORM 6-K | SEC |
| 2026-02-13 | 6-K | FORM 6-K | SEC |
| 2026-01-09 | 6-K | FORM 6-K | SEC |
| 2026-01-09 | 6-K | FORM 6-K | SEC |
| 2026-01-08 | 6-K | — | SEC |
| 2026-01-07 | 6-K | FORM 6-K | SEC |
| 2026-01-07 | 6-K | — | SEC |
| 2026-01-06 | 6-K | — | SEC |
| 2026-01-05 | 6-K | — | SEC |
| 2025-11-17 | 6-K | FORM 6-K | SEC |
| 2025-11-07 | 6-K | FORM 6-K | SEC |
| 2025-11-07 | 6-K | FORM 6-K | SEC |
| 2025-09-05 | 6-K | — | SEC |
| 2025-08-15 | 6-K | FORM 6-K | SEC |
| 2025-08-11 | 6-K | FORM 6-K | SEC |
| 2025-05-28 | 6-K | — | SEC |
| 2025-05-21 | 6-K | — | SEC |
| 2025-05-14 | 6-K | — | SEC |
| 2025-04-29 | 6-K | — | SEC |
| 2025-03-05 | 6-K | — | SEC |
| 2025-02-24 | 6-K | — | SEC |
| 2025-02-14 | 6-K | FORM 6-K | SEC |
| 2025-01-08 | 6-K | — | SEC |
| 2024-11-21 | 6-K | FORM 6-K | SEC |
| 2024-11-05 | 6-K | FORM 6-K | SEC |
| 2024-10-21 | 6-K | — | SEC |
| 2024-10-18 | 6-K | — | SEC |
| 2024-10-16 | 6-K | FORM 6-K | SEC |
| 2024-10-16 | 6-K | — | SEC |
| 2024-10-03 | 6-K | FORM 6-K | SEC |
| 2024-09-12 | 6-K | — | SEC |
| 2024-08-15 | 6-K | FORM 6-K | SEC |
| 2024-05-17 | 6-K | FORM 6-K | SEC |
| 2024-05-17 | 6-K | FORM 6-K | SEC |
| 2024-02-13 | 6-K | FORM 6-K | SEC |
出典は SEC EDGAR の 8-K／6-K。8-K は米国内企業の臨時報告（Item 2.02 が決算発表）、6-K は外国企業（ADR 含む）の対応様式です。当サイトはリンクの整理のみ行い、原文はすべて sec.gov にあります。